Navigation Links
Feinstein Institute collaborates with GSK, UPenn, MIT to research body's electrical impulses
Date:4/10/2013

MANHASSET, NY The Feinstein Institute for Medical Research today unveiled a collaboration with the University of Pennsylvania and Massachusetts Institute of Technology (MIT) being spearheaded by GlaxoSmithKline (GSK), which aims to discover medicines that use electrical impulses to regulate the body's organs and functions. This initiative is discussed in the April issue of Nature.

"This is a powerful collaboration between leaders in the field of medical device development," said Kevin J. Tracey, MD, president of the Feinstein Institute. "We are focused on developing implantable electrical devices as treatments for disease. It is likely that miniaturized, computerized technologies that target neurons will someday replace existing drugs this has the potential to be revolutionize how we think about helping patients."

Nearly all organs and functions in the body are regulated through circuits of neurons that communicate through electrical impulses. There already exist devices that use electrical impulses to treat disease (i.e., pacemakers, defibrillators, deep-brain stimulation), but these devices do not target specific cells in the body. Researchers now believe it is possible to create devices that control action potentials in individual neurons, a critical step in developing technologies to use neural circuits to control specific cells. It may be possible to intervene in a broad spectrum of diseases, like inflammatory and autoimmune diseases, because these conditions can be controlled by neurons.

The collaboration between the Feinstein Institute, GSK, MIT and University of Pennsylvania will dedicate resources with the aim to discover electrical impulse medical treatment (electroceuticals). Specifically, the Feinstein Institute will continue research on the neural codes that underlie diseases of immunity and inflammation to identify intervention points and conduct exploratory clinical work. Initial results have already shown that it is possible to manipulate neural signals specific to different inflammatory mediators in standard laboratory models.


'/>"/>

Contact: Emily Eng
eng3@nshs.edu
516-562-2670
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related biology news :

1. Feinstein Institute receives $1 million grant to study impact of World Trade Center attacks on responders
2. DOE Joint Genome Institute 8th Annual Meeting on March 26-28, 2013
3. Forsyth Institute receives $4.1 million grant for new center
4. Harvards Wyss Institute and Sony DADC announce collaboration on Organs-on-Chips
5. Sanford-Burnham Medical Research Institute and Mayo Clinic extend collaborative agreement
6. RayBiotech, Inc. Executes Neuroscience Biomarker Master Services Agreement with Banner Sun Health Research Institute
7. Scripps Research Institute study shows how brain cells shape temperature preferences
8. Salk Institute awarded historic $42 million grant from the Helmsley Charitable Trust
9. La Jolla Institute identifies molecular switch enabling immune cells to better fight disease
10. NJIT and Chinese Tech Institute join forces for 2013 Solar Decathlon in China
11. UTSA engineer Hai-Chao Han named Fellow of Medical and Biological Engineering Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... Nov. 30, 2016 Not many of us realize that we spend ? ... so we need to do it well. Inadequate sleep levels have been found to ... stroke, diabetes, and even cancer. Maybe now is the best time to ... help them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... 29, 2016 Nearly one billion matches per second ... ... DERMALOG is Germany's ... efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... 2016 AskLinkerReports.com has published a report ... Amyloglucosidase Industry 2016 Market Research Report. From a basic outline ... overview are all covered in the report. This report projects ... analysis of the Amyloglucosidase industry. ... , , ...
(Date:12/8/2016)... Dec. 8, 2016  Renova™ Therapeutics, a biotechnology ... failure and type 2 diabetes, announced that it ... adeno-associated virus (AAV) vector developed in the laboratory ... at Stanford University. The company plans to use ... therapy product pipeline. "Early research ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ability ... optogenetics — is key to exciting advances in the study and mapping of ... projected via free-space optics stimulates small, transparent organisms and excites neurons within superficial ...
(Date:12/8/2016)... England , December 8, 2016 ... das Unternehmen für Molekulargenetik, erweitert seine Palette an ... myPanel™ NGS Custom FH Panels, das ein schnelles ... (FH) ermöglicht. Das Panel bietet eine Erkennung von ... Variations (CNV) mit einem einzigen kleinen Panel und ...
Breaking Biology Technology: